Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation

Overview of attention for article published in BMC Cancer, January 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (58th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 19 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 2,235 followers.

RT @sony_tuteja: Our qualitative research study of oncology clinicians to identify barriers to preemptive #DPYD testing to guide chemothera…

20 Jan 2022

Reply Repost Favourite

RT @sony_tuteja: Our qualitative research study of oncology clinicians to identify barriers to preemptive #DPYD testing to guide chemothera…

20 Jan 2022

Reply Repost Favourite

Our qualitative research study of oncology clinicians to identify barriers to preemptive #DPYD testing to guide chemotherapy GI cancer patients is now available. https://t.co/jR9FIe73nv

19 Jan 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.